Back to Authors

Cehic, Rasima

A5017516375 | I111979921

Mayo Clinic

Northwestern University

Citations 3

A phase II study of tivozanib in patients with metastatic and non-resectable soft tissue sarcomas.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 10515-10515

10.1200/jco.2015.33.15_suppl.10515

A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS10604-TPS10604

10.1200/jco.2014.32.15_suppl.tps10604

A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas.

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 11550-11550

10.1200/jco.2018.36.15_suppl.11550